{"name":"Aescap Venture","permalink":"aescap-venture","crunchbase_url":"http://www.crunchbase.com/financial-organization/aescap-venture","homepage_url":"http://www.aescap.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+ 31 (0) 20 570 29 40","description":"Venture Capital","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Thu Jun 18 06:04:42 UTC 2009","updated_at":"Wed Dec 30 06:25:53 UTC 2009","overview":"<p>Aescap Venture is a venture capital company investing in private medical companies in Europe. </p>\n\n<p>Aescap invests in high-potential companies with realistic product opportunities and the potential to generate cashflow from licensing deals. This involves investments in all phases of development with an emphasis on earlier stages.</p>\n\n<p>Aescap Ventureâ€™s added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.</p>\n\n<p>Aescap is an acronym for â€Accelerating European Science Companies and Productsâ€ and derived from Aesculapius - the Greek god of healthcare - and capital.</p>","image":{"available_sizes":[[[150,67],"assets/images/resized/0004/9289/49289v2-max-150x150.jpg"],[[168,76],"assets/images/resized/0004/9289/49289v2-max-250x250.jpg"],[[168,76],"assets/images/resized/0004/9289/49289v2-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"Aescap","address1":"WTC World Trade Center","address2":"Strawinskylaan 1525, ","zip_code":"1077 XX","city":"Amsterdam","state_code":null,"country_code":"NLD","latitude":null,"longitude":null}],"relationships":[{"is_past":false,"title":"General partner","person":{"first_name":"Dinko","last_name":"Valerio","permalink":"dinko-valerio","image":{"available_sizes":[[[99,150],"assets/images/resized/0004/9290/49290v1-max-150x150.jpg"],[[117,176],"assets/images/resized/0004/9290/49290v1-max-250x250.jpg"],[[117,176],"assets/images/resized/0004/9290/49290v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"Rainer","last_name":"Christine","permalink":"rainer-christine","image":null}},{"is_past":false,"title":"General partner","person":{"first_name":"Michiel","last_name":"de Haan","permalink":"michiel-de-haan","image":{"available_sizes":[[[99,150],"assets/images/resized/0004/9291/49291v1-max-150x150.jpg"],[[117,176],"assets/images/resized/0004/9291/49291v1-max-250x250.jpg"],[[117,176],"assets/images/resized/0004/9291/49291v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Principal","person":{"first_name":"Hakan","last_name":"Goker","permalink":"hakan-goker-2","image":null}}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.equityhelpdesk.com/PrivateEquity/Avantium_Raises_18_Million","source_description":"Avantium Raises â‚¬18 Million","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":29,"company":{"name":"Avantium Technologies","permalink":"avantium-technologies","image":{"available_sizes":[[[150,96],"assets/images/resized/0004/9288/49288v1-max-150x150.png"],[[155,100],"assets/images/resized/0004/9288/49288v1-max-250x250.png"],[[155,100],"assets/images/resized/0004/9288/49288v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Capital Funding Report","raised_amount":30530000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":null,"company":{"name":"Vivendy Therapeutics","permalink":"vivendy-therapeutics","image":{"available_sizes":[[[150,58],"assets/images/resized/0004/9649/49649v1-max-150x150.png"],[[150,58],"assets/images/resized/0004/9649/49649v1-max-250x250.png"],[[150,58],"assets/images/resized/0004/9649/49649v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://f-star.com/press_releases/f-star_Series_A_enl.pdf","source_description":"Antibody Engineering Company F-Star Raises EUR 6.0 million in Series A Financing from Aescap Venture and Atlas Venture","raised_amount":6000000,"raised_currency_code":"EUR","funded_year":2007,"funded_month":9,"funded_day":10,"company":{"name":"f-star Biotech","permalink":"f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","image":{"available_sizes":[[[148,150],"assets/images/resized/0007/2453/72453v1-max-150x150.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-250x250.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.talentscotland.com/jobs.aspx?item_id=57820","source_description":"Aquapharm Secures Second Round Investment of Â£4M","raised_amount":4000000,"raised_currency_code":"GBP","funded_year":2007,"funded_month":7,"funded_day":26,"company":{"name":"Aquapharm Biodiscovery ","permalink":"aquapharm-biodiscovery","image":{"available_sizes":[[[150,65],"assets/images/resized/0008/0470/80470v1-max-150x150.jpg"],[[205,89],"assets/images/resized/0008/0470/80470v1-max-250x250.jpg"],[[205,89],"assets/images/resized/0008/0470/80470v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://2a.protaffin.com/images/content/pdfs/070502_ProtAffin_SeriesA_FINAL_FINAL.pdf?sid=j04ee82dd606lqgk9314o178t1","source_description":"ProtAffin AG secures Series A financing","raised_amount":2650000,"raised_currency_code":"EUR","funded_year":2007,"funded_month":5,"funded_day":4,"company":{"name":"ProtAffin Biotechnologie","permalink":"protaffin-biotechnologie","image":{"available_sizes":[[[150,90],"assets/images/resized/0008/0513/80513v1-max-150x150.jpg"],[[158,95],"assets/images/resized/0008/0513/80513v1-max-250x250.jpg"],[[158,95],"assets/images/resized/0008/0513/80513v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"https://coursework.stanford.edu/portal/site/Sp10-MS_E-271-01/page/19597d9e-1b0b-4abf-8007-c083300a5146","source_description":"Aquapharm Biodiscovery, Ltd.: Series C $6.4M ","raised_amount":6400000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":5,"company":{"name":"Aquapharm Biodiscovery ","permalink":"aquapharm-biodiscovery","image":{"available_sizes":[[[150,65],"assets/images/resized/0008/0470/80470v1-max-150x150.jpg"],[[205,89],"assets/images/resized/0008/0470/80470v1-max-250x250.jpg"],[[205,89],"assets/images/resized/0008/0470/80470v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.biocartis.com/cms/index.php?page=news","source_description":"Biocartis raises â‚¬30 million in Series â€˜B' financing round","raised_amount":41300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":8,"company":{"name":"Biocartis","permalink":"biocartis","image":{"available_sizes":[[[150,44],"assets/images/resized/0017/3531/173531v1-max-150x150.png"],[[176,52],"assets/images/resized/0017/3531/173531v1-max-250x250.png"],[[176,52],"assets/images/resized/0017/3531/173531v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2010/11/i-optics-closes-42m-third-financing.html","source_description":"i-Optics Closes â‚¬4.2M Third Financing Round","raised_amount":4200000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":11,"funded_day":1,"company":{"name":"i-Optics","permalink":"i-optics","image":{"available_sizes":[[[150,73],"assets/images/resized/0010/8222/108222v1-max-150x150.jpg"],[[250,121],"assets/images/resized/0010/8222/108222v1-max-250x250.jpg"],[[378,184],"assets/images/resized/0010/8222/108222v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://techcrunch.com/2011/06/09/avantium-funding-eur-30million/","source_description":"Shell Spinoff Avantium Raises $43.9 Million To Develop Green Plastics, Chemicals And Fuel","raised_amount":43900000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":9,"company":{"name":"Avantium Technologies","permalink":"avantium-technologies","image":{"available_sizes":[[[150,96],"assets/images/resized/0004/9288/49288v1-max-150x150.png"],[[155,100],"assets/images/resized/0004/9288/49288v1-max-250x250.png"],[[155,100],"assets/images/resized/0004/9288/49288v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.f-star.com/fstarPressRelease_3.pdf","source_description":"f-star raises â‚¬15M in a New Financing led by SR One","raised_amount":15000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":4,"funded_day":13,"company":{"name":"f-star Biotech","permalink":"f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","image":{"available_sizes":[[[148,150],"assets/images/resized/0007/2453/72453v1-max-150x150.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-250x250.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/orphazyme-lands-20m-round-back-new-drugs-rare-genetic-disorder/2011-09-07?utm_medium=rss&utm_source=rss","source_description":"Orphazyme lands $20M A round to back new drugs for rare genetic disorder","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":7,"company":{"name":"Orphazyme","permalink":"orphazyme","image":{"available_sizes":[[[150,31],"assets/images/resized/0012/8021/128021v1-max-150x150.png"],[[250,51],"assets/images/resized/0012/8021/128021v1-max-250x250.png"],[[386,80],"assets/images/resized/0012/8021/128021v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}